by Asa Elmore | May 14, 2021 | Events, News, Presentations, Press Releases
Sutro Biopharma to Participate in Upcoming Virtual Investor Conferences SOUTH SAN FRANCISCO, Calif., May 14, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise...
by Asa Elmore | May 7, 2021 | News, Press Releases
Sutro Biopharma Reports First Quarter 2021 Financial Results, Business Highlights and 2021 Anticipated Milestones – Additional follow-up data on STRO-002 from the Phase 1 dose-escalation will be presented at ASCO 2021; enrollment for the dose-expansion is...
by Asa Elmore | May 4, 2021 | Events, News, Presentations
7th Annual Truist Securities Life Sciences Summit – Presentation Webcast, Click Here Download Presentation, Click...
by Asa Elmore | Apr 20, 2021 | News, Press Releases
Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer SOUTH SAN FRANCISCO, Calif., April 20, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on...
by Asa Elmore | Apr 15, 2021 | Events, News, Presentations
20th Annual Needham Virtual Healthcare Conference – Presentation Webcast, Click Here Download Presentation, Click...
by Asa Elmore | Apr 15, 2021 | News, Press Releases
Sutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck – Initiation of an IND enabling toxicology study for the first program under the 2018 collaboration oncytokine derivatives earns a $15 million milestone payment from Merck...
